UOC
AGN

UBS O'Connor’s Allergan Inc AGN Stock Holding History

UBS O'Connor’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-460,000
Closed -$97.8M – 955
2014
Q4 		$97.8M Buy
460,000
+360,000
+360% +$71.6M 1.7% 9
2014
Q3 		$17.8M Sell
100,000
-25,000
-20% -$4.15M 0.31% 99
2014
Q2 		$21.2M Buy
+125,000
New +$19.5M 0.14% 76

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS O'Connor's AGN Position: Q1 2015 in Review

UBS O'Connor sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 460,000 shares — an estimated $97.8M sold.

UBS O'Connor first reported a position in AGN in Q2 2014 and held it in 3 quarters. The position peaked at $97.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • UBS O'Connor reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • UBS O'Connor sold 460,000 Allergan Inc shares in Q1 2015, an estimated $97.8M.
  • UBS O'Connor first reported a position in Allergan Inc in Q2 2014 and held it in 3 quarters.
  • UBS O'Connor's Allergan Inc position peaked at $97.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.